| Features | |
| Active substance | Peptide |
| Also known as | CJC-1295 without DAC, Sermorelin |
| Blood pressure | Minimal or no impact on blood pressure |
| Chemical name | Modified GRF (1-29), tetrasubstituted GRF (1-29) |
| Dosage (medical) | Typically 100 micrograms per injection, administered 1-3 times daily |
| Dosage (sports) | 100-300 micrograms per injection, 1-3 times daily |
| Effects | Increased muscle mass, reduced body fat, improved recovery and sleep |
| Formula | C152H252N44O42 |
| Half-life | Approximately 30 minutes |
| Hepatotoxicity | None |
| Lab Test | Growth hormone levels can be measured |
| Main action | Increases growth hormone secretion |
| Side effects | Pain at injection site, itching, possible gynecomastia, increased water retention |
| Storage conditions | Store in a refrigerator, avoid freezing |
| Substance class | Peptide hormone |
| Trade name | CJC-1295 without DAC |
| Use in sports | Commonly used for performance enhancement, muscle growth, and recovery |
| Water Retention | Moderate |
| Active ingredient, mg | 10 |
| Release form | Vial |
| 1 Vial, ml | 10 |
| Vials in the package, pcs | 1 |
| Manufacturer | Nouveaux |